Abstract
Background: Contrast induced encephalopathy (CIE) is an adverse event associated with diagnostic and therapeutic endovascular procedures. Decades of animal and human research support a mechanistic role for pathological blood-brain barrier dysfunction (BBBd). Here, we describe an institutional case series and review the literature supporting a mechanistic role for BBBd in CIE. Methods: A literature review was conducted by searching MEDLINE, Web of Science, Embase, CINAHL, and Cochrane databases from inception to January 31, 2022. We searched our institutional neurovascular database for cases of CIE following endovascular treatment of cerebrovascular disease during a 6-month period. Informed consent was obtained in all cases. Results: Review of the literature revealed risk factors for BBBd and CIE, including microvascular disease, pathological neuroinflammation, severe procedural hypertension, iodinated contrast load, and altered cerebral blood flow dynamics. In our institutional series, 6 of 52 (11.5%) of patients undergoing therapeutic neuroendovascular procedures developed CIE during the study period. Four patients were treated for ischemic stroke and two patients for recurrent cerebral aneurysms. Mechanical stenting or thrombectomy were utilized in all cases. Conclusion: In this institutional case series and literature review of animal and human data, we identified numerous shared risk factors for CIE and BBBd, including microvascular disease, increased procedure length, large contrast volumes, severe intra-operative hypertension, and use of mechanical devices that may induce iatrogenic endothelial injury.
Original language | English |
---|---|
Journal | Canadian Journal of Neurological Sciences |
DOIs | |
State | Accepted/In press - 1 Jan 2024 |
Externally published | Yes |
Keywords
- Contrast
- angiography
- blood brain barrier
- cerebrovascular
- encephalopathy
- endovascular
- stroke
ASJC Scopus subject areas
- Neurology
- Clinical Neurology